Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995.Natl Health Stat Rep. 2012; : 1-25
- Contraceptive methods women have ever used: United States, 1982-2010.Natl Health Stat Rep. 2013; : 1-15
- Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.Contraception. 1999; 59: 357-362
- Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women.Contraception. 2007; 75: 450-453
- Work loss associated with increased menstrual loss in the United States.Obstet Gynecol. 2002; 100: 683-687
- The trimonthly combination oral contraceptive regimen: is it cost effective?.Contraception. 1999; 60: 263-267
- Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives.Contraception. 2004; 70: 359-363
- Contraceptive failure in the United States.Contraception. 2011; 83: 397-404
- Twenty-four-month continuation of reversible contraception.Obstet Gynecol. 2013; 122: 1083-1091
- Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.Br Med J. 1977; 2: 487-490
- Menstruation: choosing whether... and when.Contraception. 2000; 62: 277-284
- Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.Contraception. 2014; 89: 299-306
- The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 mug/levonorgestrel 100 mug + ethinyl estradiol 10 mug.Int J Womens Health. 2010; 2: 235-239
- Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.Contraception. 2008; 78: 16-25
- Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.Contraception. 2006; 73: 235-243
- Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen.Obstet Gynecol. 2011; 117: 33-40
- Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.Cochrane Database Syst Rev. 2014; (CD004695)
- Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.Contraception. 1995; 51: 355-358
- A multicenter, randomized study of an extended cycle oral contraceptive.Contraception. 2003; 68: 89-96
- Comparison of rates of and charges from pregnancy complications in users of extended and cyclic combined oral contraceptive (COC) regimens: a brief report.Contraception. 2014; 89: 396-399
- Combined oral contraceptives: venous thrombosis.Cochrane Database Syst Rev. 2014; (CD010813)
- Monitoring of adverse reactions to drugs in the United Kingdom.Proc R Soc Med. 1970; 63: 1302-1304
- Extended regimens of the contraceptive vaginal ring: a randomized trial.Obstet Gynecol. 2005; 106: 473-482
- Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.Contraception. 2008; 77: 91-96
- Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.Am J Obstet Gynecol. 2006; 195: 92-96
- Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.Obstet Gynecol. 2003; 101: 653-661
- Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.Contraception. 2006; 74: 439-445
- Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?.Obstet Gynecol. 2006; 107: 657-665
- Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.Contraception. 2010; 82: 497-502
- Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.Obstet Gynecol. 2012; 119: 1143-1150
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.Fertil Steril. 2003; 80: 560-563
- Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review.Arch Gynecol Obstet. 2015; 292: 37-43
- Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.Contraception. 2007; 75: 444-449
- U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.MMWR Recomm Rep. 2013; 62: 1-60
- Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.Am J Obstet Gynecol. 2006; 195: 935-941
- Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.Contraception. 2012; 86: 110-118
- Long-term tolerability of ethinylestradiol 20 mug/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.J Fam Plann Reprod Health Care. 2012; 38: 84-93
- Extended regimens of the vaginal contraceptive ring: cycle control.Contraception. 2009; 80: 430-435
- Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.Obstet Gynecol. 2008; 112: 563-571
- Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.Obstet Gynecol. 2005; 105: 1389-1396
- Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.Contraception. 2005; 72: 168-174
- Attitudes and prescribing patterns of extended-cycle oral contraceptives.Contraception. 2011; 84: 71-75
Article info
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
